Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia

Journal of Immunology

Volumn 180, Issue 4, 2008, Pages 2459-2465

  Karunakaran, Karuna P ^a   Rey Ladino, Jose ^a   Stoynov, Nikolay ^a   Berg, Kyra ^a   Shen, Caixia ^a   Jiang, Xiaozhou ^a   Gabel, Brent R ^a   Yu, Hong ^a   Foster, Leonard J ^a   Brunham, Robert C ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUBUNIT VACCINE; T LYMPHOCYTE ANTIGEN; BACTERIAL ANTIGEN; H2 ANTIGEN; HLA ANTIGEN CLASS 2; PEPTIDE; PROTEOME;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CELL TRANSFER; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; FEMALE; GENITAL SYSTEM; GENITAL TRACT INFECTION; LUNG INFECTION; MOLECULE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEOMICS; T LYMPHOCYTE; TANDEM MASS SPECTROMETRY; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; HELA CELL; HUMAN; IMMUNOLOGY; INTRACELLULAR FLUID; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; PROTEIN BINDING; TRANSPLANTATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; DENDRITIC CELLS; FEMALE; H-2 ANTIGENS; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTRACELLULAR FLUID; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEOME; TANDEM MASS SPECTROMETRY;

EID: 42149120753     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.4.2459     Document Type: Article

References (46)

1. WHO. 2001. Global prevalence and incidence of selected curable sexually transmitted diseases. In World Health Organization Report, WHO, General Switzerland, 10-13.
2. Plummer, F. A., J. N. Simonsen, D. W. Cameron, J. O. Ndinya-Achola, J. K. Kreiss, M. N. Gakinya, P. Waiyaki, M. Cheang, P. Piot, A. R. Ronald, et al. 1991. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J. Infect. Dis. 163: 233-239.
3. Koskela, P., T. Anttila, T. Bjorge, A. Brunsvig, J. Dillner, M. Hakama, T. Hakulinen, E. Jellum, M. Lehtinen, P. Lenner, et al. 2000. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int. J. Cancer 85: 35-39.
4. Brunham, R. C., B. Pourbohloul, S. Mak, R. White, and M. L. Rekart. 2005. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J. Infect. Dis. 192: 1836-1844.
5. Wang, S. P., J. T. Grayston, and E. R. Alexander. 1967. Trachoma vaccine studies in monkeys. Am. J. Ophthalmol. 63(Suppl.): 1615-1630.
6. Brunham, R. C., and J. Rey-Ladino. 2005. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 5: 149-161.
7. Morrison, S. G., and R. P. Morrison. 2005. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J. Immunol. 175: 7536-7542.
8. Seder, R. A., and A. V. Hill. 2000. Vaccines against intracellular infections requiring cellular immunity. Nature 406: 793-798.
9. Stephens, R. S., S. Kalman, C. Lammel, J. Fan, R. Marathe, L. Aravind, W. Mitchell, L. Olinger, R. L. Tatusov, Q. Zhao, et al. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282: 754-759.
10. Read, T. D., R. C. Brunham, C. Shen, S. R. Gill, J. F. Heidelberg, O. White, E. K. Hickey, J. Peterson, T. Utterback, K. Berry, et al. 2000. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 28: 1397-1406.
11. Steinman, R. M., and M. Pope. 2002. Exploiting dendritic cells to improve vaccine efficacy. J. Clin. Invest. 109: 1519-1526.
12. Su, H., R. Messer, W. Whitmire, E. Fischer, J. C. Portis, and H. D. Caldwell. 1998. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J. Exp. Med. 188: 809-818.
13. Lu, H., Z. Xing, and R. C. Brunham. 2002. GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis. J. Immunol. 169: 6324-6331.
14. Rey-Ladino, J., K. M. Koochesfahani, M. L. Zaharik, C. Shen, and R. C. Brunham. 2005. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct. Infect. Immun. 73: 1568-1577.
15. Zaharik, M. L., T. Nayar, R. White, C. Ma, B. A. Vallance, N. Straka, X. Jiang, J. Rey-Ladino, C. Shen, and R. C. Brunham. 2007. Genetic profiling of dendritic cells exposed to live- or ultraviolet-irradiated Chlamydia muridarum reveals marked differences in CXC chemokine profiles. Immunology 120: 160-172.
16. de Jong, A. 1998. Contribution of mass spectrometry to contemporary immunology. Mass Spectrom. Rev. 17: 311-335.
17. Olsen, J. V., L. M. de Godoy, G. Li, B. Macek, P. Mortensen, R. Pesch, A. Makarov, O. Lange, S. Horning, and M. Mann. 2005. Parts per million mass accuracy on an orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell. Proteomics 4: 2010-2021.
18. Janeway, C. A., Jr., P. J. Conrad, E. A. Lerner, J. Babich, P. Wettstein, and D. B. Murphy. 1984. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. J. Immunol. 132: 662-667.
19. Wall, K. A., M. I. Lorber, M. R. Loken, S. McClatchey, and F. W. Fitch. 1983. Inhibition of proliferation of MIs- and Ia-reactive cloned T cells by a monoclonal antibody against a determinant shared by I-A and I-E. J. Immunol. 131: 1056-1064.
20. b haplotype reveal genetic control of isotype expression. J. Immunol. 126: 317-321.
21. Cox, A., E. L. Huczko, V. H. Engelhard, J. Shabanowitz, and D. F. Hunt. 1997. The application of mass spectrometry to the analysis of peptides bound to MHC molecules. In MHC: A Practical Approach, Vol. 1. N. Fernandez and G. Butcher, eds. Oxford Univ. Press, Oxford, pp. 142-160.
22. Chan, Q. W., C. G. Howes, and L. J. Foster. 2006. Quantitative comparison of caste differences in honeybee hemolymph. Mol. Cell. Proteomics 5: 2252-2262.
23. Fink, J. L., R. N. Aturaliya, M. J. Davis, F. Zhang, K. Hanson, M. S. Teasdale, C. Kai, J. Kawai, P. Carninci, Y. Hayashizaki, and R. D. Teasdale. 2006. Locate: a mouse protein subcellular localization database. Nucleic Acids Res. 34: D213-D217.
24. Ioannou, X. P., P. Griebel, R. Hecker, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 2002. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J. Virol. 76: 9002-9010.
25. Baca-Estrada, M. E., M. Snider, S. K. Tikoo, R. Harland, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 1996. Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: effect of antigen form on the induction of cellular and humoral immune responses. Viral Immunol. 9: 11-22.
26. Bilenki, L., S. Wang, J. Yang, Y. Fan, A. G. Joyee, and X. Yang. 2005. NK T cell activation promotes Chlamydia trachomatis infection in vivo. J. Immunol. 175: 3197-3206.
27. Rammensee, H. G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228.
28. Trombetta, E. S., and I. Mellman. 2005. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23: 975-1028.
29. Rappuoli, R. 2000. Reverse vaccinology. Curr. Opin. Microbiol. 3: 445-450.
30. Panigada, M., T. Sturniolo, G. Besozzi, M. G. Boccieri, F. Sinigaglia, G. G. Grassi, and F. Grassi. 2002. Identification of a promiscuous T-cell epitope in Mycobacterium tuberculosis Mce proteins. Infect. Immun. 70: 79-85.
31. Doolan, D. L., S. Southwood, R. Chesnut, E. Appella, E. Gomez, A. Richards, Y. I. Higashimoto, A. Maewal, J. Sidney, R. A. Gramzinski, et al. 2000. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocyticstage antigens restricted by multiple HLA class II alleles. J. Immunol. 165: 1123-1137.
32. Wilson, C. C., B. Palmer, S. Southwood, J. Sidney, Y. Higashimoto, E. Appella, R. Chesnut, A. Sette, and B. D. Livingston. 2001. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes. J. Virol. 75: 4195-4207.
33. + Tc1 responses that inhibit intracellular growth of this vacuolar pathogen. J. Immunol. 169: 2524-2535.
34. +)-cell responses to vaccinia virus. Nat. Biotechnol. 24: 817-819.
35. Lund, O., M. Nielsen, C. Lundegaard, C. Kesmir, and S. Brunak. 2005. Immunological Bioinformatics. MIT Press, Cambridge, MA.
36. + T cells. Cell. Immunol. 242: 110-117.
37. Tan, C., J. K. Spitznagel, H.-Z. Shou, R.-C. Hsia, and P. M. Bavoil. 2006. The polymorphic membrane protein gene family of the Chlamydiaceae. In Chlamydia: Genomics and Pathogenesis. P. M. Bavoil and P. B. Wyrick, eds. Horizon Scientific Press, Norfolk, U.K., pp. 195-218.
38. Carlson, J. H., S. F. Porcella, G. McClarty, and H. D. Caldwell. 2005. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect. Immun. 73: 6407-6418.
39. Gomes, J. P., A. Nunes, W. J. Bruno, M. J. Borrego, C. Florindo, and D. Dean. 2006. Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: evidence for serovar Da recombination and correlation with tissue tropism. J. Bacteriol. 188: 275-286.
40. Nunes, A., J. P. Gomes, S. Mead, C. Florindo, H. Correia, M. J. Borrego, and D. Dean. 2007. Comparative expression profiling of the Chlamydia trachomatis pmp gene family for clinical and reference strains. PLoS ONE 2: e878.
41. + T cell-mediated response to polymorphic membrane proteins of Chlamydia pneumoniae during experimental infection. FEMS Immunol. Med. Microbiol. 40: 129-137.
42. Peeling, R. W., J. Kimani, F. Plummer, I. Maclean, M. Cheang, J. Bwayo, and R. C. Brunham. 1997. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J. Infect. Dis. 175: 1153-1158.
43. Cohen, C. R., K. M. Koochesfahani, A. S. Meier, C. Shen, K. Karunakaran, B. Ondondo, T. Kinyari, N. R. Mugo, R. Nguti, and R. C. Brunham. 2005. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-γ. J. Infect. Dis. 192: 591-599.
44. + T cells. Infect. Immun. 68: 6979-6987.
45. Subtil, A., C. Delevoye, M. E. Balana, L. Tastevin, S. Perrinet, and A. Dautry-Varsat. 2005. A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol. Microbiol. 56: 1636-1647.
46. Misaghi, S., Z. R. Balsara, A. Catic, E. Spooner, H. L. Ploegh, and M. N. Starnbach. 2006. Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol. Microbiol. 61: 142-150.